AGP Picks
View all

Djibouti Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Djibouti Health Journal.

Press releases published on November 3, 2026

RxSight, Inc. Reports Third Quarter 2026 Results
InnovAge Announces Financial Results for the Fiscal First Quarter Ended September 30, 2026
Zevra Reports Third Quarter 2026 Financial Results and Corporate Update
Iridex to Report Third Quarter 2026 Financial Results on November 17, 2026
Ceribell Reports Third Quarter 2026 Financial Results
Tarsus Reports Third Quarter 2026 Financial Results
Alamar Biosciences Reports Third Quarter 2026 Financial Results and Raises 2026 Revenue Guidance
Treace to Present at the Stifel 2026 Healthcare Conference
Mineralys Therapeutics to Participate in Upcoming Investor Conferences
MacroGenics Announces Appointments of Emil Kuriakose, M.D., and Michael Vasconcelles, M.D., to Board of Directors
Alamar Biosciences Partners with GSK on Large-Scale Proteomic Study to Advance Precision Medicine
Globus Medical Acquires Synaptive Medical, Strengthening Its Position in Cranial Neurosurgery
Aura Biosciences to Participate in Upcoming Investor Conference
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
Xenon to Present at Upcoming Investor Conferences
Spyre Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Nurix Therapeutics Announces Sanofi’s Decision to Discontinue Development of STAT6 Degrader SAR448272
Monte Rosa Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Ardelyx Reports Third Quarter 2026 Financial Results and Provides Business Update
Denali Therapeutics Reports Third Quarter 2026 Financial Results and Business Highlights

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Djibouti Health Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.